Genmab — Oktober 2023

[E_L]

Janssen Submits Application to the European Medicines Agency for RYBREVANT▼ (amivantamab) in Combination with Chemotherapy for the First-Line Treatment of Adult Patients with Advanced Non-Small Cell Lung Cancer with Activating EGFR Exon 20 Insertion Mutations https://www.globenewswire.com/news-release/2023/10/06/2755961/0/en/Janssen-Submits-Application-to-the-European-Medicines-Agency-for-RYBREVANT-amivantamab-in-Combination-with-Chemotherapy-for-the-First-Line-Treatment-of-Adult-Patients-with-

[Vitus]

Håber da Darzalex patentsagen ender positivt….

[JKY_VH]

Det kan vi da håbe Vitus

[E_L]

anything of interest in that medwatch/Novo article?

[E_L]

AMGEN COMPLETES ACQUISITION OF HORIZON THERAPEUTICS PLC https://www.prnewswire.com/news-releases/amgen-completes-acquisition-of-horizon-therapeutics-plc-301949517.html --> let's start that Tepezza push

[ProinvestorNEWS]

Rapport fra Stifel omkring situtationen for biotek https://www.proinvestor.com/boards/115979

[peter12]

Lidt om gen3014 h2hhttps://www.clinical-lymphoma-myeloma-leukemia.com/article/S2152-2650(23)01668-3/pdf

[Bulder]

Ja, så mangler vi bare resultaterne. Næsten uudholdeligt spændende. Det er ikke store ord, de bruger om de foreløbige resultater: tolerabel sikkerhedsprofil og påvist klinisk aktivitet.

[Bulder]

16 mg/kg, det er det samme som IV dara. Så skulle der vel kunne fikses en sc version.

[Bulder]

I givet fald.

[E_L]

Tepkinly European public assessment report if you really have nothing to do this weekend https://www.ema.europa.eu/en/medicines/human/EPAR/tepkinly

[peter12]

We're waiting for a brief summary. What does orphan mean for the drug in this context ?

[E_L]

https://www.ema.europa.eu/en/human-regulatory/overview/orphan-designation-overview
https://www.ema.europa.eu/en/human-regulatory/research-development/orphan-designation/orphan-incentives

[peter12]

Ok thanks,
so it still need to be approved before use

[E_L]

epcoritamab has had EMA orphan status since early 2022, it should all be there in those documents somewhere

[ProinvestorNEWS]

Dagens aktie er AbbVie Inc.

AbbVie er en amerikansk børsnoteret biofarmaceutisk virksomhed der opstod som spin-off af Abbott Laboratories
62+ mio. mennesker behandles årlig med produkter fra AbbVie på tværs af 60+ sygdomme.
Primære områder er Immunologi - Onkologi - Virologi - Neurologi - Æstetik https://www.proinvestor.com/boards/116020

[E_L]

Eddie Cliff

@Eddie_Cliff
? ? Exciting sneak peek of some of the first efficacy data of bispecific antibodies in R/R CLL: epcoritamab

• 32% complete responses, ORR 58% https://twitter.com/Eddie_Cliff/status/1711090884094095701

[E_L]

Amgen gennemfører købet af Horizon til 200 milliarder kroner
Med handlen får Genmab en ny samarbejdspartner. https://medwatch.dk/Medicinal___Biotek/article16495947.ece?utm_medium=latestNews

[JKY_VH]

Tak for den E L, en lille god "nyhed" for Genmab.

[JKY_VH]

I så fald må rente ned "Storbank: Recessionen rammer snart" https://borsen.dk/nyheder/perspektiv/chefokonom-i-storbank-rentestigninger-gor-ondt-nu-recessionen-rammer-snart?b_source=borsen&b_medium=row_1&b_campaign=list_1